Combating HER2-overexpressing breast cancer through induction of calreticulin exposure by Tras-Permut CrossMab.
about
The use of CrossMAb technology for the generation of bi- and multispecific antibodies.Functionally Active Fc Mutant Antibodies Recognizing Cancer Antigens Generated Rapidly at High Yields.Structural and functional characterization of MBS301, an afucosylated bispecific anti-HER2 antibodyMicroRNA-645 targets urokinase plasminogen activator and decreases the invasive growth of MDA-MB-231 triple-negative breast cancer cells
P2860
Combating HER2-overexpressing breast cancer through induction of calreticulin exposure by Tras-Permut CrossMab.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Combating HER2-overexpressing ...... osure by Tras-Permut CrossMab.
@ast
Combating HER2-overexpressing ...... osure by Tras-Permut CrossMab.
@en
type
label
Combating HER2-overexpressing ...... osure by Tras-Permut CrossMab.
@ast
Combating HER2-overexpressing ...... osure by Tras-Permut CrossMab.
@en
prefLabel
Combating HER2-overexpressing ...... osure by Tras-Permut CrossMab.
@ast
Combating HER2-overexpressing ...... osure by Tras-Permut CrossMab.
@en
P2093
P2860
P1433
P1476
Combating HER2-overexpressing ...... osure by Tras-Permut CrossMab.
@en
P2093
Junlan Yang
Lichao Zhao
RuiXia LingHu
Shunchang Jiao
Xudong Gao
P2860
P304
P356
10.4161/2162402X.2014.994391
P577
2015-01-22T00:00:00Z